Cargando…

Tolvaptan rescue contrast-induced acute kidney injury: A case report

RATIONALE: Contrast-induced acute kidney injury is one of the most serious adverse effects of contrast media and is related to three distinct but interacting mechanisms: medullary ischemia, formation of reactive oxygen species and direct tubular cell toxicity, especially in the patients with chronic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Wei-Chieh, Fang, Hsiu-Yu, Fang, Chih-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944520/ https://www.ncbi.nlm.nih.gov/pubmed/29703048 http://dx.doi.org/10.1097/MD.0000000000010570

Ejemplares similares

Tolvaptan Improves Contrast-Induced Acute Kidney Injury
por: Xu, Chunyang, et al.
Publicado: (2022)

Tolvaptan in the Treatment of Acute Hyponatremia Associated with Acute Kidney Injury
por: Gopinath, Shilpa, et al.
Publicado: (2013)

Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury
por: Gibson, Andrew, et al.
Publicado: (2020)

Risk and protective factors of acute kidney injury in decompensated cirrhotic patients with ascites on tolvaptan
por: Kogiso, Tomomi, et al.
Publicado: (2021)

Contrast-induced Acute Kidney Injury
por: Ramachandran, Pratheema, et al.
Publicado: (2020)

Tolvaptan-induced Liver Injury: Who is at Risk? A Case Report and Literature Review
por: Khan, Muhammad Y, et al.
Publicado: (2019)

Tolvaptan
por: Rangarajan, Bharath, et al.
Publicado: (2014)

Tolvaptan in ADPKD Patients With Very Low Kidney Function
por: Torres, Vicente E., et al.
Publicado: (2021)

Contrast-induced Acute Kidney Injury and Inflammation
por: Yun, Kyeong Ho
Publicado: (2017)

The conundrum of contrast-induced acute kidney injury
por: Haq, Mohammad Faraz Ul, et al.
Publicado: (2020)

Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report
por: Kunizawa, Kyohei, et al.
Publicado: (2018)

A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium
por: Wu, Jiajia, et al.
Publicado: (2022)

Novel Biomarkers for Contrast-Induced Acute Kidney Injury
por: Briguori, Carlo, et al.
Publicado: (2014)

Case report: a thiazide diuretic to treat polyuria induced by tolvaptan
por: Kramers, Bart J., et al.
Publicado: (2018)

Impact of chronic kidney disease on the diuretic response of tolvaptan in acute decompensated heart failure
por: Ikeda, Shuntaro, et al.
Publicado: (2017)

Antegrade approach for closure of distal and torturous congenital coronary artery fistula: A case report
por: Lee, Wei-Chieh, et al.
Publicado: (2018)

Tolvaptan, Kidney Function Decline, and Potential Confounding by Muscle Wasting
por: Groothof, Dion, et al.
Publicado: (2023)

Contrast-Associated Acute Kidney Injury
por: Mandurino-Mirizzi, Alessandro, et al.
Publicado: (2022)

Nonpharmacological Strategies to Prevent Contrast-Induced Acute Kidney Injury
por: Susantitaphong, Paweena, et al.
Publicado: (2014)

Pharmacological Strategies to Prevent Contrast-Induced Acute Kidney Injury
por: Pattharanitima, Pattharawin, et al.
Publicado: (2014)

Contrast-Induced Acute Kidney Injury: Definition, Epidemiology, and Outcome
por: Meinel, Felix G., et al.
Publicado: (2014)

Contrast-Induced Acute Kidney Injury: Review and Practical Update
por: Morcos, Ramez, et al.
Publicado: (2019)

Urinary proteomics investigations into contrast-induced acute kidney injury
por: Zhu, Hong, et al.
Publicado: (2021)

Contrast-induced acute kidney injury and its contemporary prevention
por: Sůva, Marek, et al.
Publicado: (2022)

The Potential Biotherapeutic Targets of Contrast-Induced Acute Kidney Injury
por: Cheng, Alice Shasha, et al.
Publicado: (2023)

Tolvaptan ameliorated kidney function for one elderly autosomal dominant polycystic kidney disease patient: A case report
por: Zhou, Li, et al.
Publicado: (2022)

Long-term Tolvaptan Treatment of Autosomal Dominant Polycystic Kidney Disease in Korea
por: Kim, Ha Yeon, et al.
Publicado: (2018)

Contrast-induced acute kidney injury/contrast-induced nephropathy may be related to additional risk factors
por: Ünal, Hilmi Umut, et al.
Publicado: (2018)

Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure
por: Katsumata, Mari, et al.
Publicado: (2017)

Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease
por: Gilbert, Rodney D., et al.
Publicado: (2017)

Safety Profile of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease
por: Bellos, Ioannis
Publicado: (2021)

Paricalcitol Attenuates Contrast-Induced Acute Kidney Injury by Regulating Mitophagy and Senescence
por: Bae, Eunjin, et al.
Publicado: (2020)

Impact of Chronic Kidney Disease on Chronic Total Occlusion Revascularization Outcomes: A Meta-Analysis
por: Lee, Wei-Chieh, et al.
Publicado: (2021)

A case report with shock induced by tolvaptan in an elderly patient with congestive heart failure
por: Zhang, Zhi-gang, et al.
Publicado: (2018)

Machine Learning to Predict Contrast-Induced Acute Kidney Injury in Patients With Acute Myocardial Infarction
por: Sun, Ling, et al.
Publicado: (2020)

Metformin, arterial contrast and acute kidney injury
por: Amos, Lal, et al.
Publicado: (2019)

Incidence and risk of developing contrast-induced acute kidney injury following intravascular contrast administration in elderly patients
por: Song, Wei, et al.
Publicado: (2013)

Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2)
por: Lameire, Norbert, et al.
Publicado: (2013)

The potential use of biomarkers in predicting contrast-induced acute kidney injury
por: Andreucci, Michele, et al.
Publicado: (2016)

Histopathological Evaluation of Contrast-Induced Acute Kidney Injury Rodent Models
por: Kiss, Norbert, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qgtv4f3endis93crukklcgsms5